Facial Erythema Treatment Market Trends

Statistics for the 2023 & 2024 Facial Erythema Treatment market trends, created by Mordor Intelligence™ Industry Reports. Facial Erythema Treatment trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Facial Erythema Treatment Industry

This section covers the major market trends shaping the Facial Erythema Treatment Market according to our research experts:

Antibiotics Segment is Estimated to Hold the Largest Share of the Market

By drug type, the facial erythema treatment market has been segmented into Antibiotics, Antifungal, Antihistamines, Corticosteroids, and Others. Antibiotics can reduce the number of acne pimples and bacterial inflammation or redness. It is most commonly preferred by physicians and doctors as compared to other types for early relief from the disease. Topical metronidazole antibiotic is commonly used as a first-line agent. The high demand for antibiotics in the treatment of rosacea is the main factor for the growth of the market. However, there are certain side effects associated with the usage of antibiotics, including bloating, loss of appetite, abdominal pain, and many others, which is expected to restrain their adoption in the forecast period.

Facial Erythema Treatment Market 1

North America dominates the Facial Erythema Treatment Market

North America has multiple factors, which support the growth of this market, better than other geographic regions. Some factors include high healthcare expenditure by the government each year on pharmaceuticals and medical devices and awareness in the society. As per the estimates of the National Rosacea Society (NRS), in 2018 about 16 million Americans suffer from rosacea. Such trends are expected to push more patients suffering from symptoms of facial erythema to approach clinics and hospitals, which boosts the studied market in the region. The region is also supported by multiple international companies being collaborated with many major hospital chains, which drives the business of the studied market.

Asia-Pacific is expected to be explored more over the forecast period by the international companies because of the larger target patient pool, changing lifestyle and rapid population growth, better economic growth with higher importance to healthcare facilities and increase in research and development activities.

Facial Erythema Treatment Market 2

Facial Erythema Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)